DNA, Xoma long-term Raptiva data

Genentech (DNA) and partner XOMA reported open-label data for their Raptiva efalizumab to treat moderate to severe psoriasis that DNA said could support long-term

Read the full 240 word article

How to gain access

Continue reading with a
two-week free trial.